Rhumbline Advisers Kaleido Biosciences, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.05 - $1.7 $869 - $29,569
-17,394 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$1.3 - $2.7 $1,561 - $3,242
1,201 Added 7.42%
17,394 $29,000
Q4 2021

Feb 10, 2022
BUY
$2.39 - $6.02 $13,905 - $35,024
5,818 Added 56.08%
16,193 $39,000
Q3 2021

Nov 12, 2021
SELL
$5.36 - $7.99 $2,503 - $3,731
-467 Reduced 4.31%
10,375 $57,000
Q2 2021

Aug 05, 2021
BUY
$5.82 - $8.72 $63,100 - $94,542
10,842 New
10,842 $81,000

Others Institutions Holding KLDO

# of Institutions
2
Shares Held
2.65K
Call Options Held
0
Put Options Held
0
View Full List

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email